I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
The Competition DG makes the information provided by the notifying parties in section 4 of Short Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.
This notification concerns the following undertakings:
• MEP SHELFCO XIII S.À R.L. ("BidCo"), organised under the laws of the Grand Duchy of Luxembourg, and controlled by MidEuropa V Management Limited (together with all other entities within the same undertaking, "MidEuropa"), which is based in Great Britian.
• MPILO S.À R.L. ("Target"), incorporated and existing under the laws of the Grand Duchy of Luxembourg, and controlled by EAD S.À R.L. ("Seller") which is also incorporated and existing under the laws of the Grand Duchy of Luxembourg.
BidCo acquires, within the meaning of Article 3(1), point (b) of the Merger Regulation, sole control of the the Target.
The concentration is being accomplished by way of a purchase of the entire issued share capital of Target by BidCo from the Seller pursuant to the SPA.
(a) BidCo is a special purpose vehicle used by MidEuropa solely for the purposes of acquiring the Target.
(b) MidEuropa V Management Limited is the General Partner to Mid Europa Fund V, a fund structure acquiring, holding, monitoring and disposing of investments in Central and Eastern Europe. The wider MidEuropa group is a European private equity investor focusing on businesses across the consumer, healthcare, services and technology sectors.
(c) Target is the holding company of the Famar group of companies ("Famar Group"), which are active in the pharmaceutical contract development and manufacturing market. The Famar Group provides development and manufacturing services to the pharmaceutical industry in relation to various medicines and molecules.
Commission européenne/Europese Commissie, 1049 Bruxelles/Brussel, BELGIQUE/BELGIË - Tel. +32 22991111